Stocks Screener

Specify Company / Ticker to Get the Summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Electrocore LLC

ECOR
Current price
7.57 USD +0.11 USD (+1.47%)
Last closed 6.59 USD
ISIN US28531P2020
Sector Healthcare
Industry Medical Devices
Exchange NASDAQ
Capitalization 54 307 832 USD
Yield for 12 month +32.81 %
1Y
3Y
5Y
10Y
15Y
ECOR
21.11.2021 - 28.11.2021

electroCore, Inc., a bioelectronic medicine and general wellness company, provides non-invasive vagus nerve stimulation ("nVNS") technology platform in the United States, the United Kingdom, and internationally. The company develops gammaCore, a prescription only handheld device intended for regular or intermittent use for the acute treatment of pain associated with migraine and episodic cluster headache, as well as for the treatment of hemicrania continua and paroxysmal hemicrania. It also develops Truvaga 350, a personal use consumer electronics general wellness product and Truvaga Plus, an, app-enabled general wellness product. In addition, the company offers TAC-STIM for human performance and gammaCore Sapphire, a portable, reusable, rechargeable, and reloadable prescription medical device for various primary headache conditions. electroCore, Inc. was incorporated in 2005 and is headquartered in Rockaway, New Jersey. Address: 200 Forge Way, Rockaway, NJ, United States, 07866

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

25.20 USD

P/E ratio

Dividend Yield

Current Year

+25 182 000 USD

Last Year

+16 030 000 USD

Current Quarter

+7 046 000 USD

Last Quarter

+6 554 000 USD

Current Year

+21 397 000 USD

Last Year

+13 226 000 USD

Current Quarter

+6 052 000 USD

Last Quarter

+5 489 000 USD

Key Figures ECOR

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -11 402 000 USD
Operating Margin TTM -43.59 %
Price to Earnings
Return On Assets TTM -41.57 %
PEG Ratio
Return On Equity TTM -158.63 %
Wall Street Target Price 25.20 USD
Revenue TTM 25 182 000 USD
Book Value 1.13 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY 35.70 %
Dividend Yield
Gross Profit TTM 21 397 000 USD
Earnings per share -1.83 USD
Diluted Eps TTM -1.83 USD
Most Recent Quarter IV 2024
Quarterly Earnings Growth YOY
Profit Margin -47.20 %

Dividend Analytics ECOR

Max Ratio

>10 - expected double digit dividend yield on cost over 10Y >5 - expected 5-9 dividend yield on cost over 10Y <5 - expected <5 dividend yield on cost over 10Y MaxRatio is an estimated 10Y dividend yield on cost calculated by combining the current dividend yield with the 5-year & 10-year average dividend growth rate, projected over the next 10 years discounted based on current Financial Score. It provides a projected outlook on future dividend returns.

5Y Dividend Growth

Consecutive Years

5Y Average Payout Ratio

Dividend History ECOR

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Ex Dividend Date
Dividend CAGR 3Y
Dividend CAGR 5Y
Dividend CAGR 10Y
Consecutive Years
Consistent Years
Continuous Dividends
Forward Annual Dividend Yield
Forward Annual Dividend – USD
Last Split Factor 1:15
Payout Ratio TTM
Last Split Date 15.02.2023

Stock Valuation ECOR

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 1.85
Price Sales TTM 2.16
Enterprise Value EBITDA 0.16
Price Book MRQ 7.20

Financials ECOR

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators ECOR

For 52 weeks

5.02 USD 19.49 USD
50 Day MA 10.41 USD
Shares Short Prior Month 288 107
200 Day MA 10.31 USD
Short Ratio 1.18
Shares Short 262 078
Short Percent 9.35 %